Home
|
Job-opportunities
|
Contact
|
News
|
Donate
Overview
DNDi Worldwide
Business Model
Stakeholders
Friends of DNDi
Our People
Annual Report
DNDi's Policies
Endorsements
Letter from Chairman and Executive Director
Diseases
Portfolio
R&D Organisation
Building Portfolio
Clinical Trial Protocols
Open Innovation
ASAQ
ASMQ
NECT
SSG&PM
Paediatric Benznidazole
LEAP Platform
HAT Platform
Chagas Platform
Technology transfer ASMQ
Technology transfer ASAQ
Global
Access
IP
Regulatory
Sustainable Funding
Press Kit
Press Releases
Press Articles
Scientific Publications
Newsletters
Outlooks
Multimedia
Events
Press Room
Business Model
Partners
IP & Licensing Policies
To Become a DNDi Partner
How to help
Donors
Key Financial Figures
Fundraising Policy
Donate
Home
LEAP Platform
Publications
Overview
LEAP Platform
Publications
HAT Platform
Chagas Platform
Technology Transfer ASMQ
Technology Transfer ASAQ
Publications
LEAP Brochure (English)
, April 2011
LEAP Brochure (Deutsch)
, April 2011
DND
i
Newsletters about the platform:
Newsletter No. 18
, June 2009
LEAP: A step into the right direction
VL clinical studies in East Africa
Newsletter: No. 16
, June 2008;
Newsletter: No. 8
, January-March 2004;
Newsletter: No. 7
, September-December 2003.
Press releases about the platform:
Press release
: Geneva, 22 November 2004, DND
i
Clinical Trials for Paromomycin begin in Sudan.
SITEMAP
DISCLAIMER
PRIVACY
Except where otherwise noted, content on this site is licensed under
a Creative Commons Attribution-Noncommercial-Share Alike 2.5 Switzerland License